메뉴 건너뛰기




Volumn 27, Issue 2, 2012, Pages 63-71

Five-year outcomes of Cypher™ coronary stent: Report from J-PMS Study

Author keywords

Anti platelet therapy; Drug eluting stent; Follow up studies

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CYPHER; RAPAMYCIN; THIENOPYRIDINE DERIVATIVE; TICLOPIDINE; UNCLASSIFIED DRUG;

EID: 84861516224     PISSN: 18684300     EISSN: 18684297     Source Type: Journal    
DOI: 10.1007/s12928-011-0092-x     Document Type: Article
Times cited : (14)

References (18)
  • 1
    • 0141765805 scopus 로고    scopus 로고
    • Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery
    • Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003; 349: 1315-23.
    • (2003) N Engl J Med , vol.349 , pp. 1315-1323
    • Moses, J.W.1    Leon, M.B.2    Popma, J.J.3    Fitzgerald, P.J.4    Holmes, D.R.5    O'Shaughnessy, C.6
  • 2
    • 67649975510 scopus 로고    scopus 로고
    • Assessment of sirolimus-eluting coronary stent implantation with aspirin plus low dose ticlopidine administration: one year results from CYPHER Stent Japan Post-Marketing Surveillance Registry (J-PMS)
    • Ikari Y, Kotani J, Kozuma K, Kyo E, Nakamura M, Yokoi H, et al. Assessment of sirolimus-eluting coronary stent implantation with aspirin plus low dose ticlopidine administration: one year results from CYPHER Stent Japan Post-Marketing Surveillance Registry (J-PMS). Circ J. 2009; 73: 1038-44.
    • (2009) Circ J , vol.73 , pp. 1038-1044
    • Ikari, Y.1    Kotani, J.2    Kozuma, K.3    Kyo, E.4    Nakamura, M.5    Yokoi, H.6
  • 3
    • 79251572664 scopus 로고    scopus 로고
    • Clinical and angiographic outcomes with sirolimus-eluting stent for coronary bifurcation lesions. The J-PMS study
    • Kozuma K, Ota Y, Nagai Y, Katsuta Y, Nozaki E, Onodera T, et al. Clinical and angiographic outcomes with sirolimus-eluting stent for coronary bifurcation lesions. The J-PMS study. Circ J. 2010; 5: 306-14.
    • (2010) Circ J , vol.5 , pp. 306-314
    • Kozuma, K.1    Ota, Y.2    Nagai, Y.3    Katsuta, Y.4    Nozaki, E.5    Onodera, T.6
  • 4
    • 34247558672 scopus 로고    scopus 로고
    • Clinical end points in coronary stent trials: a case for standardized definitions
    • Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007; 115: 2344-51.
    • (2007) Circulation , vol.115 , pp. 2344-2351
    • Cutlip, D.E.1    Windecker, S.2    Mehran, R.3    Boam, A.4    Cohen, D.J.5    van Es, G.A.6
  • 5
    • 6944237687 scopus 로고    scopus 로고
    • Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy
    • McFadden EP, Stabile E, Regar E, Cheneau E, Ong AT, Kinnaird T, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet. 2004; 364: 1519-21.
    • (2004) Lancet , vol.364 , pp. 1519-1521
    • McFadden, E.P.1    Stabile, E.2    Regar, E.3    Cheneau, E.4    Ong, A.T.5    Kinnaird, T.6
  • 6
    • 61849093662 scopus 로고    scopus 로고
    • Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation
    • Kimura T, Morimoto T, Nakagawa Y, Tamura T, Kadota K, Yasumoto H, et al. Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation. Circulation. 2009; 119: 987-95.
    • (2009) Circulation , vol.119 , pp. 987-995
    • Kimura, T.1    Morimoto, T.2    Nakagawa, Y.3    Tamura, T.4    Kadota, K.5    Yasumoto, H.6
  • 7
    • 33847167065 scopus 로고    scopus 로고
    • Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study
    • Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet. 2007; 369: 667-78.
    • (2007) Lancet , vol.369 , pp. 667-678
    • Daemen, J.1    Wenaweser, P.2    Tsuchida, K.3    Abrecht, L.4    Vaina, S.5    Morger, C.6
  • 8
    • 77954621329 scopus 로고    scopus 로고
    • Comparisons of baseline demographics, clinical presentation, and long-term outcome among patients with early, late, and very late stent thrombosis of sirolimus-eluting stents: observations from the Registry of Stent Thrombosis for Review and Reevaluation (RESTART)
    • Kimura T, Morimoto T, Kozuma K, Honda Y, Kume T, Aizawa T, et al. Comparisons of baseline demographics, clinical presentation, and long-term outcome among patients with early, late, and very late stent thrombosis of sirolimus-eluting stents: observations from the Registry of Stent Thrombosis for Review and Reevaluation (RESTART). Circulation. 2010; 122: 52-61.
    • (2010) Circulation , vol.122 , pp. 52-61
    • Kimura, T.1    Morimoto, T.2    Kozuma, K.3    Honda, Y.4    Kume, T.5    Aizawa, T.6
  • 10
    • 0034811280 scopus 로고    scopus 로고
    • Influence of planned six-month follow-up angiography on late outcome after percutaneous coronary intervention: a randomized study
    • ten Berg JM, Kelder JC, Suttorp MJ, Verheugt FW, Thijs Plokker HW. Influence of planned six-month follow-up angiography on late outcome after percutaneous coronary intervention: a randomized study. J Am Coll Cardiol. 2001; 38: 1061-9.
    • (2001) J Am Coll Cardiol , vol.38 , pp. 1061-1069
    • ten Berg, J.M.1    Kelder, J.C.2    Suttorp, M.J.3    Verheugt, F.W.4    Thijs Plokker, H.W.5
  • 11
    • 64649084378 scopus 로고    scopus 로고
    • Five-year follow-up after sirolimus-eluting stent implantation results of the SIRIUS (sirolimus-eluting stent in de novo native coronary lesions) Trial
    • Weisz G, Leon MB, Holmes DR Jr, Kereiakes DJ, Popma JJ, Teirstein PS, et al. Five-year follow-up after sirolimus-eluting stent implantation results of the SIRIUS (sirolimus-eluting stent in de novo native coronary lesions) Trial. J Am Coll Cardiol. 2009; 53: 1488-97.
    • (2009) J Am Coll Cardiol , vol.53 , pp. 1488-1497
    • Weisz, G.1    Leon, M.B.2    Holmes Jr., D.R.3    Kereiakes, D.J.4    Popma, J.J.5    Teirstein, P.S.6
  • 12
    • 41449108482 scopus 로고    scopus 로고
    • Four-year clinical follow-up of the rapamycin-eluting stent evaluated at Rotterdam Cardiology Hospital registry
    • Daemen J, Kukreja N, van Twisk PH, Onuma Y, de Jaegere PP, van Domburg R, et al. Four-year clinical follow-up of the rapamycin-eluting stent evaluated at Rotterdam Cardiology Hospital registry. Am J Cardiol. 2008; 101: 1105-11.
    • (2008) Am J Cardiol , vol.101 , pp. 1105-1111
    • Daemen, J.1    Kukreja, N.2    van Twisk, P.H.3    Onuma, Y.4    de Jaegere, P.P.5    van Domburg, R.6
  • 13
    • 79953693894 scopus 로고    scopus 로고
    • Comparison of haemodialysis patients and non-haemodialysis patients with respect to clinical characteristics and 3-year clinical outcomes after sirolimus-eluting stent implantation: insights from the Japan multi-centre post-marketing surveillance registry
    • Otsuka Y, Ishiwata S, Inada T, Kanno H, Kyo E, Hayashi Y, et al. Comparison of haemodialysis patients and non-haemodialysis patients with respect to clinical characteristics and 3-year clinical outcomes after sirolimus-eluting stent implantation: insights from the Japan multi-centre post-marketing surveillance registry. Eur Heart J. 2011; 32: 829-837.
    • (2011) Eur Heart J. , vol.32 , pp. 829-837
    • Otsuka, Y.1    Ishiwata, S.2    Inada, T.3    Kanno, H.4    Kyo, E.5    Hayashi, Y.6
  • 14
    • 78649711929 scopus 로고    scopus 로고
    • Impact of insulin-treated diabetes and hemodialysis on long-term clinical outcomes following sirolimus-eluting stent deployment. Insights from a sub-study of the Cypher Stent Japan Post-Marketing Surveillance (Cypher J-PMS) Registry
    • Nakamura M, Yokoi H, Hamazaki Y, Watarai M, Kijima M, Mitsudo K. Impact of insulin-treated diabetes and hemodialysis on long-term clinical outcomes following sirolimus-eluting stent deployment. Insights from a sub-study of the Cypher Stent Japan Post-Marketing Surveillance (Cypher J-PMS) Registry. Circ J. 2010; 74: 2592-7.
    • (2010) Circ J , vol.74 , pp. 2592-2597
    • Nakamura, M.1    Yokoi, H.2    Hamazaki, Y.3    Watarai, M.4    Kijima, M.5    Mitsudo, K.6
  • 15
    • 76449085829 scopus 로고    scopus 로고
    • Impact of multiple and long sirolimus-eluting stent implantation on 3-year clinical outcomes in the j-Cypher Registry
    • Shirai S, Kimura T, Nobuyoshi M, Morimoto T, Ando K, Soga Y, et al. Impact of multiple and long sirolimus-eluting stent implantation on 3-year clinical outcomes in the j-Cypher Registry. JACC Cardiovasc Interv. 2009; 3: 180-8.
    • (2009) JACC Cardiovasc Interv. , vol.3 , pp. 180-188
    • Shirai, S.1    Kimura, T.2    Nobuyoshi, M.3    Morimoto, T.4    Ando, K.5    Soga, Y.6
  • 16
    • 79956277262 scopus 로고    scopus 로고
    • Long-term safety and efficacy of paclitaxel-eluting stents final 5-year analysis from the TAXUS clinical trial program
    • Stone GW, Ellis SG, Colombo A, Grube E, Popma JJ, Uchida T, et al. Long-term safety and efficacy of paclitaxel-eluting stents final 5-year analysis from the TAXUS clinical trial program. JACC Cardiovasc Interv. 2011; 4: 530-42.
    • (2011) JACC Cardiovasc Interv. , vol.4 , pp. 530-542
    • Stone, G.W.1    Ellis, S.G.2    Colombo, A.3    Grube, E.4    Popma, J.J.5    Uchida, T.6
  • 17
    • 34547860049 scopus 로고    scopus 로고
    • Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment
    • Airoldi F, Colombo A, Morici N, Latib A, Cosgrave J, Buellesfeld L, et al. Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment. Circulation. 2007; 116: 745-54.
    • (2007) Circulation. , vol.116 , pp. 745-754
    • Airoldi, F.1    Colombo, A.2    Morici, N.3    Latib, A.4    Cosgrave, J.5    Buellesfeld, L.6
  • 18
    • 77951001904 scopus 로고    scopus 로고
    • Duration of dual antiplatelet therapy after implantation of drug-eluting stents
    • Park SJ, Park DW, Kim YH, Kang SJ, Lee SW, Lee CW, et al. Duration of dual antiplatelet therapy after implantation of drug-eluting stents. N Engl J Med. 2010; 362: 1374-82.
    • (2010) N Engl J Med , vol.362 , pp. 1374-1382
    • Park, S.J.1    Park, D.W.2    Kim, Y.H.3    Kang, S.J.4    Lee, S.W.5    Lee, C.W.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.